{"id":15642,"date":"2012-02-14T00:00:00","date_gmt":"2012-02-13T22:00:00","guid":{"rendered":"http:\/\/www.bio-based.eu\/news\/index.php?startid=20120214-02n"},"modified":"2012-02-14T00:00:00","modified_gmt":"2012-02-13T22:00:00","slug":"investments-in-biotech","status":"publish","type":"post","link":"https:\/\/renewable-carbon.eu\/news\/investments-in-biotech\/","title":{"rendered":"Investments in Biotech"},"content":{"rendered":"<p><b>What\u2019s the forecast for biotech in 2012? Do investors think it is a good time to invest in biotechnology? Are they interested in taking on early stage companies?<\/b><\/p>\n<p>At the BIO CEO &#038; Investor Conference opening plenary, the BIO Industry Analysis team released results from their Investor Perception Study and, afterwards, a panel of portfolio managers and senior buy-side analysts fielded a range of question about the challenges and opportunities facing the industry. David Gluckman, M.D., managing director and co-head of North American Life Sciences, moderated the panel that included:<\/p>\n<p>Alexander J. Denner, PhD, (former) Managing Director, Icahn Associates<br \/>Rajiv Kaul, Portfolio Manager, Fidelity Select Biotechnology Portfolio, <a href=\"http:\/\/www.fidelity.com\/\" >Fidelity<\/a><br \/>Greg Martinez, Portfolio Manager, Diamondback Capital Management LLC<br \/>Deepa R. Pakianathan, PhD, General Partner, <a href=\"http:\/\/www.delphiventures.com\/\" >Delphi Ventures<\/a><\/p>\n<p><i>&#8230; Full Text: <a href=\"http:\/\/www.biotech-now.org\/events\/2012\/02\/picks-and-pans-%E2%80%93-the-buy-side-view-for-2012\" >http:\/\/www.biotech-now.org\/events\/2012\/02\/picks-and-pans-\u2013-the-buy-side-view-for-2012<\/a><\/p>\n<p>Tags: forecast for 2012, biotechnology<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p><b>What&rsquo;s the forecast for biotech in 2012? Do investors think it is a good time to invest in biotechnology? Are they interested in taking on<\/b><\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"","nova_meta_subtitle":"","footnotes":""},"categories":[5572],"tags":[],"supplier":[3191],"class_list":["post-15642","post","type-post","status-publish","format-standard","hentry","category-bio-based","supplier-north-american-life-sciences"],"_links":{"self":[{"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/posts\/15642","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/comments?post=15642"}],"version-history":[{"count":0,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/posts\/15642\/revisions"}],"wp:attachment":[{"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/media?parent=15642"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/categories?post=15642"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/tags?post=15642"},{"taxonomy":"supplier","embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/supplier?post=15642"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}